chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states that at 11:00am on 10/30/2023  she started experiencing numbness in both arms.  Patient also states that it feel uncomfortable
mom called c/o nonstop crying for approx 2 hrs; unable to settle pt on day p/vax; parent felt abn behavior & reported occurence;
There were no side effects with the 1st dose.  The 2nd dose resulted in the following:   4 hrs in:  2 hives on thigh 12 hrs in:  More hives/welts on torso, feet, knees, elbows, hands, face, thighs 24 hrs in:  fever, chills, body aches (expected) and extensive amount of welts, hives all over the body and  swollen hands/feet, wrists/ankles to include itching and pain. The 2nd dose has triggered my Chronic Urticaria, which I first got in 2019 from what I believe was an ingredient in sunscreen (octinoxate).  At that time it took me 1 long year to completely get rid of those hives and that was successful by using a series of prednisone (which was damaging to my system and hard to get off of) and then finally Xolair.  I have not been off of the Xolair for even a year at this point and now, I am back to where I started.   I believe that the PEGs in the Pfizer vaccine has activated my urticaria.  I am now suffering with severe welts/hives and swollen hands.  Prednisone is not an option due to it mixing with the vaccine and I managed to get a low dose of Xolair yesterday (4/12/21) but that shot is slow-absorbing and I might not see relief for 7-8 days.  Additionally, my blood pressure was 160/100, which is consistent with presence of these welts/hives.  This includes a rapid heart beat as well. Had I known this was a even a remote possibility, I would not have received the Pfizer vaccine.  Chronic Hives is a life-altering issue as I have used a lot of sick time and missed events due to discomfort and swollen eyelids.
Slight induration at sites of injection and redness over majority of thigh. Nontender to palpation, induration only over site of injection, about 1.5 x 1.5 cm.
Information has been received from a physician's assistant concerning a male who on 01, Feb 2007 was vaccinated SC with a "single dose vial" of zoster vaccine live (Oka/Merck). Within about a week after being vaccinated approximately on 08, Feb 2007, the patient experienced "pain in the left rib area" and was diagnosed with having herpes zoster. Physician Assistant reported that the patient was treated with acyclovir 800 mg and gabapantin (NEURONTIN) 100 mg. Medical attention was sought. The patient's outcome was not reported. The product quality complaint was not involved. Additional information has been requested.
Cannot sleep; Itchy rash that is uncomfortable on arms and legs; High fever; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Cannot sleep), RASH PRURITIC (Itchy rash that is uncomfortable on arms and legs) and PYREXIA (High fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.  Concurrent medical conditions included Diabetes. Concomitant products included EMPAGLIFLOZIN (JARDIANCE) for Diabetes.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced PYREXIA (High fever). On 29-Apr-2021, the patient experienced RASH PRURITIC (Itchy rash that is uncomfortable on arms and legs). On an unknown date, the patient experienced SLEEP DISORDER (Cannot sleep). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Fever, at an unspecified dose and frequency and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Rash, at an unspecified dose and frequency. On 26-Apr-2021, PYREXIA (High fever) had resolved. At the time of the report, SLEEP DISORDER (Cannot sleep) and RASH PRURITIC (Itchy rash that is uncomfortable on arms and legs) outcome was unknown.  DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Apr-2021, Body temperature: 103 (High) 103 Fahrenheit.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Day 1  - energy drain tired 4 hours post injection Day 2 - Swollen and tender Axillary Lymph Nodes both arms, tired Day 3 and 4  and 5- Tired, nausea, chills and sweats, body aches, deep bone pain and stiffness, excessive thirst Day 5 - increasing neck and shoulder pain, heat in shoulders, inflammatory response in old injury sites Day 6 - deep bone pain, soaking sweats, exhaustion, sharp and tightening neck pain and headache Day 7 - so far so good
Patient developed chills, malaise on the evening of his second Moderna vaccine dose (3/25/2021). He then began to have 3-4 days of HAs, nausea, vomiting, fatigue. Slowly improving, but symptoms are still persistent over 7 days after vaccination. Of note, patient had his first Moderna COVID vaccine on 2/25/2021 and he had tested positive for COVID-19 on 10/25/2020.
Scattered bruising and petechiae noted on both lower legs approx. 6 hrs after IM injections received in each anterolateral thigh.
A spontaneous case report was received from a nurse for two patients (husband and wife) on 12-Jul-2017. Based on the information obtained from the nurse, two individual case safety reports PVX201707-000601 (PVX2017-2334; husband) and PVX201707-000602 (PVX2017-2343; wife) were created and cross-linked in the database. This case report describes an elderly male patient who "took Vaxchora in his 70's". The patient was receiving oral Vaxchora for an unknown indication. It was reported that the patient was administered Vaxchora in the age of 70's on 11-Jul-2017. The action taken with VIVOTIF with respect to the event "took Vaxchora in his 70's" was not applicable. The clinical outcome of the event "took Vaxchora in his 70's" was unknown. Company's comment: The causality of the event "product use in unapproved population" was considered as not applicable.; Reporter's Comments: The causality of the event "product use in unapproved population" was considered as not applicable.; Sender's Comments: The causality of the event "product use in unapproved population" was considered as not applicable.
Coughing; Shortness of breath; Loss of energy; Rapid heart rate. I went to the ER for these symptoms. They tested me for a pulmonary embolism and I did not have it. I spoke to my doctor. I took a lot of tests. I was diagnosed with CMV and mononucleosis. I was recommended to see a hematologist and pulmonologist. I continued to take many tests.
Had varivax. Developed varicella. Seen by me 9/10/02.
Rash on palm of hands 7 days after vaccination. Red spots only on palms with slight itch and sting  Rash developed on soles of feet at the end of day 7. Same style of rash.   Day 8 resulted in uncomfortable swelling and flush skin around rash. Rash is warm to touch. Rash is slightly itchy and moderate stinging when trying to close fist or hold items or walking on feet.   Ibuprofen and Benadryl manage symptoms to the point they are tolerable but annoying.
Patient began with complaints of pain on 02/24/2005 at approximately 20:00(10:00) By 02/25/2005 at 7:00 left deltoid hot, red and swollen. MD notified and diphenhydramine 50mg PO started by Dr x48 hours. Ice packs given.
Urticaria  noticed on left wrist within 10 minutes of vaccine. After 3 hours, chest and back had urticaria. Lymph edema exacerbated significantly. 4 days of urticaria subsided after use of antihistamines. Still working through worst lymph edema since lymph node biopsy.
Information has been received from a medical assistant referring to unspecified patients of unknown age and gender. Information about medical history and concurrent conditions were unspecified. On unknown dates the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot # L021214, expiry date 10-JUN-2017, dose and route were unknown). The vaccine experienced a temperature excursions (temperature 15.8 F, time frame: 14 hours and 30 minutes). There was no previous excursions. It was a data logger and back in range. No adverse effect reported. This is one of two reports received from the same source. Additional information is not expected because there was no consent for follow up.
Complaint of severe pain to injection site 5 days after received. Redness and swelling to site present.
Round red area about 2" in diameter occurred on day 8 after Moderna vaccination 1, covid 19.
"pains in my stomach on the left side from under my breast to my umbilicus. they are not intestinal, but more superficial.  It is a general soreness with periodic stabbing pains." --still continuing after 5 days post vaccination
I fainted in the stairwell of my apartment building (on a landing) a little less than 24 hours after the second Pfizer dose. Before fainting, I felt lightheaded. After fainting and waking up (I was out for a few seconds), I was sweating. Luckily, I was not injured as a neighbor grabbed me and prevented me from falling down the stairs and hitting my head.
Before I gave the vaccine to patient,  I asked if he had why allergy or allergic  reaction to any vaccine , and his was "No". I asked if he has any  health condition that we should be aware off, his answer is "No". patient did not mention that he passed out (fainted) before after his blood  drawn 10 years ago until after the incident. (after receiving covid vaccine). Patient refused us to call ambulance or medical  help. Patient was told to sit down and was offered some water to drink.  I asked if patient was OK, he said he was ok. I told patient to let his family member know to pick him up in case he cannot drive home.
Itching, small bump (hive size), redness at site of injection  Moderna COVTD-19 Vaccine EUA
Major vaccination site pain; Tiredness; Headache; Major muscle pain; Chills; Joint pain; Fever; Feeling unwell; Dizziness; Weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus and COVID-19. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 09:00, the patient experienced major vaccination site pain, tiredness, headache, major muscle pain, chills, joint pain, fever, feeling unwell, dizziness and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as a result of reported event. The clinical outcomes of major vaccination site pain, tiredness, headache, major muscle pain, chills, fever, feeling unwell, dizziness and weakness were recovered with sequelae on an unknown date in Apr2021. The clinical outcome of joint pain was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Right lower eyelid twitching; Sore deltoid muscle; This is a spontaneous report from a contactable healthcare professional, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via intramuscular route of administration in the left arm on 02Jul2021 at 11:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to sulfa and penicillin. The patient did not receive any concomitant medications. prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via intramuscular route of administration in the left arm on 11Jun2021 at 11:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. On 09Jun2021 the patient experienced sore deltoid muscle and right lower eyelid twitching. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events sore deltoid muscle and right lower eyelid twitching was not resolved at the time of this report.
Cause I am past menopause for several years now and all week since the injection I?ve been experiencing hot flashes. I have not had hot flashes from menopause in several years. I find this quite unusual. It?s lasted  nearly a week so far. It concerns me that the vaccine can impact hormones.
09/20/21 The patient presents with 48 year old female who tested positive for COVID-19 on 09/10 and received Regeneron on 09/18. She states her symptoms have worsened. Statess she had intractable nausea, vomiting, diarrhea and a near syncopal episodes today. Denies: abdominal pain, headache, head trauma.  The onset was 10  days ago.   The degree at present is moderate.  Risk factors consist of hypertension and COVID-19 (09/10).  Therapy today: none.  Associated symptoms: nausea, vomiting, diarrhea, denies chest pain, denies abdominal pain, denies shortness of breath, denies fever, denies chills, denies headache, denies dizziness, denies back pain.
Expanding area of redness/swollen around injection site. Regular Physician put me on Keflex on 04/04/2011.
Client notified local health department on 10.18.2021 that she has been experiencing strange things since she received her first dose of pfizer on 9.29.2021. Client stated some symptoms began the evening she received the vaccine - that night she noticed her voice became really hoarse and still is today. she also stated she was confused and very emotional ("crying for no reason") that night she received the vaccine. Stated she was confused for 6 days post vaccination. Client stated she typically has some shortness of breath normally d/t history of CHF but she felt like her SOB has increased significantly since vaccination - starting the night of vaccination and still has not improved. She also noticed "sores" on her tongue the day after vaccination - sores are now resolved. Client also c/o lack of taste, increase in saliva, and increase in coughing since vaccinated. Client stated she has not been seen for any of these symptoms as she currently does not have health insurance. Client stated she reached out via MyChart to her primary care doctor on 10.2.2021 and her cardiologist on 10.5.2021 with no response. Writer encouraged client to call cardiologist as many of her symptoms may be d/t worsening CHF.
Baby crying for 24hrs, fever 104.9; took child to MD 6MAY91 MD stated it was a rxn to the vax; Return to MD 10MAY91 w/the same problems; MD stated it would just take sometime to recover;
left breast pain; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (left breast pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported). Concurrent medical conditions included Hypertension. Concomitant products included VITAMINS NOS for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced BREAST PAIN (left breast pain). At the time of the report, BREAST PAIN (left breast pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included High Blood Pressure medication, acid reflux medication, Cranberry supplement and Cinnamon supplement. Treatment medication were not provided/unknown.
pt started rolling eyes;it was reported that this behavior cont on & off;@ time of report pt getting worse & rolling eyes a lot more;pt seen by MD & dx w/complex partial sz;exp considered an important medical event;
Legs collapsed while playing tennis and I fell. They felt almost foreign and unresponsive and weak. A general lethargy was also present, with an energy level far lower than normal for me, one who is in excellent health normally and extremely strong and quick for my age (tournament level tennis player). Since the first indication of a problem the weakness has increased to present and now I have such little control of my legs in activities that I no longer try to play tennis as it is too dangerous. I have fallen twice just standing, with my legs collapsing each time. Before this tetanus shot I never had such a problem. I take no drugs, and only vitamins. I have low heart beat (58-60) and my last blood pressure test was 115/65. Regardless of activity I am now sleeping 10-12 hours per day and am still lethargic. Before the tetanus shot I slept about 10 hours also but was a bundle of energy, as one would have to be to compete with much younger quality tennis players, many of whom are tennis coaches too.
fatigue Arm soreness for more than 10 days site of injection very red- large circular area covering most of upper arm, area was itchy and hot for several days Primary Healthcare Provider was notified
This spontaneous report was received from a Registered Nurse, via Pfizer, Inc. (manufacturer control number 2016262812) on 16-JUN-2016, referring to a 13 month old female patient. The patient has none medical history or concurrent conditions or concomitant therapies. On 01-MAR-2016, the patient was vaccinated with doses of improperly stored ROTATEQ lot # L006184, orally, (Dosage, dose number and expiration date were not reported). Other suspect therapies included PREVNAR 13, PENTACEL, and ENGERIX-B, vaccines given on the same date. No other concomitants therapies were reported. No product quality complain was involved. Additional information has been requested.
Very sore arm, massive earache, shooting pain in right temple. Ibuprofen helped. Felt fine by Sunday
The follow up received on 1/29/03 states welps all around injection site; started Tuesday until Sunday-sore/swollen Rt arm.
Initial report received from a consumer on 19 September 2014. A 46-year-old female patient, had received a dose of INFLUENZA VACCINE (Manufacturer-unknown, lot number, dose number, route and anatomical site of administration not reported) on an unknown date and had received a dose of PNEUMOCCAL VACCINE (Manufacturer- unknown, lot number, dose number, route and anatomical site of administration not reported) on an unknown date. The patient previously received COPAXONE from 1 Jan 1997 to 1 Jan 2004 and AVENOX from 1 Jan 20104 to 1 Aug 2014 as a previous MS therapy. On an unknown date after vaccination patient had experienced her arm was swollen and has a rash and also states, "I am hardly able to walk". It was reported that patient had not started on AUBAGIO yet. It was reported that patient experienced pneumonia every year; however patient physician wanted to vaccinate with pneumonia vaccine. Corrective treatment and laboratory details were not reported. At the time of this report, patient outcome was unknown. Documents held by sender: None.
Severe left sided facial pain; Possible trigeminal neuralgia; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 26-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 12Oct2023 at 13:00 as dose 1, single (Lot number: HG4633) at the age of 26 years, in left arm for covid-19 immunisation; for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: INFLUENZA taken for immunisation, on 09Oct2023 as dose number unknown, single. Vaccination history included: Covid-19 vaccine (Unknown Manufacturer, DOSE 3 (BOOSTER), SINGLE), for Covid-19 immunization; Covid-19 vaccine (Unknown Manufacturer, Primary Immunization Series Completed), for Covid-19 immunization. No covid tested prior or post vaccination. No known allergies. No other medications in two weeks. The following information was reported: TRIGEMINAL NEURALGIA (hospitalization) with onset 12Oct2023 at 18:00, outcome "recovering", described as "Possible trigeminal neuralgia"; FACIAL PAIN (hospitalization) with onset 12Oct2023 at 18:00, outcome "recovering", described as "Severe left sided facial pain". Severe left sided facial pain that required hospitalization for pain management. Workup for possible trigeminal neuralgia. The patient was hospitalized for facial pain, trigeminal neuralgia (hospitalization duration: 5 day(s)). The events "severe left sided facial pain" and "possible trigeminal neuralgia" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of facial pain, trigeminal neuralgia. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided, and a temporal association, a causal association between reported events and suspect BNT162B2 omi xbb.1.5cannot be excluded. This impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Received Td injection on 5/31/07 and presented to the walk-in clinic on 6-2-07 with redness pain and swelling at the injection site. Dx'd with cellulitis.
5 min after shot immediate headache and felt faint.  Went to bed and next day tired but ok.  About one month later and continuing a very odd fatigue, normal activity then will feel if I have to suddenly sit or lay down.  Almost daily now.  No headache, illness or other, just feel suddenly very tired.  Usually rest from 10 -15 min then ok but may have a few hours of activity then ok or have to stop again.  No consistent pattern.   I hike and backpack.  Used to be able to do that most of a day. Now 4-5 hours and am exhausted.  Very odd.  Also I have never had covid to my knowledge.  I had the Jansen shot first and was tired but no real noticeable effects.  Had the Pfizer as a booster about 7 months later.  I have had no additional boosters and if I do it will not be pfizer for sure.
This spontaneous report has been received from a Bachelor of Science in Nursing refers to a patient who was vaccinated with the first dose of VAQTA on 27-DEC-1995 and the second dose on 22-MAY-1996. No adverse effect was reported. It was unknown if the patient sought medical attention. At the time of report, the patient's status was unknown. Additional information has been requested.